Analyst Ratings for MacroGenics (MGNX)
MGNX Rating Summary
MGNX Price Target Summary
- Highest: $5.00 (Stifel)
- Lowest: $3.00 (Barclays)
- Average: $4.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$4.00 (+79.4%)
* Over Last 12-Mos
Rating Score: 5.2 / 10
Percentile Rank: 56%
Avg. $ Target:
$4.00 (+79.4%)
* Over Last 12-Mos
Rating Score: 5.2 / 10
Percentile Rank: 56%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/17/2025 | Barclays | Etzer Darout | New Coverage | Overweight (N/A) |
3.00 (N/A) |
1.56 (2.23) |
42.95% | Details |
| 11/7/2024 | Citizens » Updated 2/24/2026 |
Silvan Turkcan | Downgrade | Market Perform (Market Outperform) |
N/A (N/A) |
3.77 (2.23) |
-40.85% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
